Valuation : GC Genome Corporation

Market Cap 133B 98.04M 84.58M 79.68M 72.6M 136M 9.26B 137M 943M 366M 4.74B 368M 360M 15.55B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 73.75M 54.31K 46.85K 44.13K 40.21K 75.16K 5.13M 75.72K 522K 203K 2.62M 204K 199K 8.62M EV / Sales 2026 *
1.89x
EV / Sales 2027 * 1.32x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day-4.41%
1 week+1.44%
Current month-4.90%
1 month+22.39%
3 months+0.90%
6 months-31.59%
Current year-17.45%
1 week 5,520
Extreme 5520
5,970
1 month 4,865
Extreme 4865
6,050
Current year 4,100
Extreme 4100
9,520
1 year 4,100
Extreme 4100
9,520
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 2020-03-25
Director of Finance/CFO 50 2025-03-26
Comptroller/Controller/Auditor 45 2024-03-28
Director TitleAgeSince
Director/Board Member 57 2023-03-29
Date Insider Type Main position Quantity % Market Cap. Importance
6/17/25 Free

Chief Executive Officer

169,285 -
6/17/25 Free 138,250 --
Change 5-day change 1-year change 3-year change Capi.($)
-4.41%+1.44%-23.92% - 102M
+1.37%-3.93%+92.02%+420.10% 46.24B
+1.24%-1.21%+21.14%+60.55% 26.57B
+0.83%-5.97%-16.89%-41.16% 6.94B
+0.24%-1.01%+7.67%+132.42% 5.94B
+0.61%-1.09%+18.71%+74.09% 3.35B
+2.25%-3.95%-32.35%+1,829.25% 2.53B
-0.29%+0.17%+97.50%+14.70% 2.24B
+5.30%+5.41%+29.15%+33.54% 2.03B
-2.60%-5.64%-13.69%-55.31% 1.88B
Average +0.46%-1.44%+17.93%+274.24% 9.78B
Weighted average by Cap. +1.19%-3.45%+50.85%+270.19%

Financials

2026 *2027 *
Net sales 39B 28.72M 24.77M 23.34M 21.26M 39.74M 2.71B 40.04M 276M 107M 1.39B 108M 105M 4.56B 48.8B 35.93M 31M 29.2M 26.61M 49.73M 3.39B 50.1M 346M 134M 1.74B 135M 132M 5.7B
Net income - -
Net Debt -59.4B -43.74M -37.73M -35.54M -32.39M -60.53M -4.13B -60.99M -421M -163M -2.11B -164M -161M -6.94B -68.8B -50.66M -43.7M -41.17M -37.51M -70.11M -4.79B -70.64M -487M -189M -2.45B -190M -186M -8.04B
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
26-09-02 ₩5,630.00 -4.41% 45,383
26-09-01 ₩5,890.00 -0.51% 32,139
26-08-31 ₩5,920.00 -0.84% 69,081
26-08-28 ₩5,970.00 +6.61% 90,451
26-08-27 ₩5,600.00 +0.90% 134,911

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock